Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Monitor and Document Psychotropic Medication Use

Shelton, Washington Survey Completed on 06-09-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that psychotropic medications were regularly monitored and properly documented for two residents. For one resident with diagnoses including depression, anxiety disorder, dementia with psychotic disturbance, and psychosis, the electronic health record showed missing documentation for behavior monitoring related to delusions, hallucinations, and paranoia on several dates. Additionally, side effect monitoring for both antipsychotic and antidepressant medications was either missing or not documented for multiple days, with no antidepressant side effect monitoring found for two consecutive months. Staff interviews confirmed that these omissions did not meet facility expectations for monitoring and documentation. For another resident with bipolar disorder and depression, there was no documentation of adverse side effect monitoring for a prescribed mood stabilizer. The resident was also taking an antipsychotic medication that required regular AIMS testing, but the required monitoring was not completed in a timely manner, despite a pharmacist's recommendation. Staff acknowledged that side effect monitoring and timely follow-through on pharmacist recommendations were expected but not performed in these cases.

An unhandled error has occurred. Reload 🗙